Amgen and Boston Children's Hospital to identify new targets for pain syndromes

Amgen has entered a neuroscience research collaboration with Boston Children's Hospital to find new genes and drug targets for severe pain syndromes based on human genetic analyses.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news